The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence and risk factors of cetuximab-induced hypersensitivity infusion reactions (HIRs).
S. Hopps
No relevant relationships to disclose
E. Borders
No relevant relationships to disclose
P. Medina
No relevant relationships to disclose
M. Moorman
No relevant relationships to disclose
R. Webb
No relevant relationships to disclose
C. Kurkjian
No relevant relationships to disclose
S. Pant
No relevant relationships to disclose